These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27327421)

  • 41. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention.
    Vitale C; Miceli M; Rosano GM
    Climacteric; 2007 Oct; 10 Suppl 2():16-20. PubMed ID: 17882667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists.
    Collins P; Rosano G; Casey C; Daly C; Gambacciani M; Hadji P; Kaaja R; Mikkola T; Palacios S; Preston R; Simon T; Stevenson J; Stramba-Badiale M
    Climacteric; 2007 Dec; 10(6):508-26. PubMed ID: 18049944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Menopause-related risks and hormone therapy in diabetic women].
    Gaspard U; van den Brûle F
    Rev Med Liege; 2005; 60(5-6):586-9. PubMed ID: 16035332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The severity of menopausal symptoms and cardiovascular risk in women].
    Isaeva AS; Vovchenko MN
    Georgian Med News; 2014 Jun; (231):21-6. PubMed ID: 25020165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of menopause.
    Castelo-Branco C; Rostro F
    Minerva Ginecol; 2006 Apr; 58(2):137-52. PubMed ID: 16582869
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hormone therapy and cardiovascular disease--still much to be learnt.
    Mikkola TS; Ylikorkala O
    Gynecol Endocrinol; 2005 Feb; 20(2):116-20. PubMed ID: 15823832
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diabetes and the menopause.
    Wedisinghe L; Perera M
    Maturitas; 2009 Jul; 63(3):200-3. PubMed ID: 19535207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic implications of menopause.
    Polotsky HN; Polotsky AJ
    Semin Reprod Med; 2010 Sep; 28(5):426-34. PubMed ID: 20865657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Survey on epidemiologic factors associated with the age of natural menopause and menopausal symptoms in Jiangsu women].
    Li L; Wu J; Jiang XQ; Pu DH; Zhao Y
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):728-33. PubMed ID: 24406127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
    J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of aging and menopause on lipids and lipoproteins in women.
    Kolovou GD; Bilianou HG
    Angiology; 2008; 59(2 Suppl):54S-7S. PubMed ID: 18515273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sex differences in cardiovascular risk factors and disease prevention.
    Appelman Y; van Rijn BB; Ten Haaf ME; Boersma E; Peters SA
    Atherosclerosis; 2015 Jul; 241(1):211-8. PubMed ID: 25670232
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-invasive cardiovascular risk assessment in women with type 2 diabetes.
    Penckofer S; Filliung DR; Labropoulos N
    J Vasc Nurs; 2005 Mar; 23(1):2-7; quiz 8-9. PubMed ID: 15741957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Bittner V
    Expert Opin Pharmacother; 2009 Sep; 10(13):2041-53. PubMed ID: 19563274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
    Davey DA
    Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists.
    Collins P; Rosano G; Casey C; Daly C; Gambacciani M; Hadji P; Kaaja R; Mikkola T; Palacios S; Preston R; Simon T; Stevenson J; Stramba-Badiale M
    Eur Heart J; 2007 Aug; 28(16):2028-40. PubMed ID: 17644507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Association between breast arterial calcifications and cardiovascular risk factors in menopausal women].
    de Almeida OJ; Vieira MM; Alvares BR; Pinto Neto AM; Pimenta CJ
    Rev Bras Ginecol Obstet; 2014 Jul; 36(7):315-9. PubMed ID: 25076072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular disease after menopause: a growing epidemic.
    Alexander J; Clearfield M
    Minerva Ginecol; 2006 Feb; 58(1):35-40. PubMed ID: 16498369
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The medical management of menopause: to treat or not to treat?
    Barlow DH
    Ann N Y Acad Sci; 2008 Apr; 1127():134-9. PubMed ID: 18443341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.